CrushSCI.com
提供学术论文选刊润色服务
BREAST 期刊封面 医学
返回期刊列表

Review Cycle Records

BREAST

Elsevier SCIE OA
2026新锐 2区2025中科院 2区2025 JCR Q1
137.7平均天数
128中位天数
55最短天数
307最长天数
7492025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

133 天

Cost-effectiveness of abbreviated breast MRI and contrast-enhanced mammography for women with extremely dense breasts in a national breast cancer screening program: a micro-simulation study

作者Mengmeng Li; Marcel J.W. Greuter; Keris Poelhekken; Monique D. Dorrius; Karin M. Vermeulen; Antoinette D.I. van Asselt; Geertruida H. de Bock

作者单位Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Health Science, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

PDF源文件 DOI 网页
123 天

Revisiting HER2-negative breast cancer in the era of HER2-low and HER2-ultralow expression: Assessment of interobserver variability

作者Xiao Huang; Sarah Anderson; Valeria Dal Zotto; Shuko Harada; Andrea G Kahn; Meiling Zhou; Kui Zhang; Kanako Okamoto; Shi Wei

作者单位Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Mathematical Sciences, Michigan Technological University, Houghton, MI, USA; Department of Statistics, Grand Valley State University, Allendale, MI, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA

PDF源文件 DOI 网页
55 天

End-of-life care values and treatment preferences among Japanese breast cancer patients and families: A dyadic cross-sectional study

作者Akemi Hara; Ayu Ajitomi; Kazunoshin Tachibana; Kenji Gonda; Masahiro Wada; Rui Omori; Megumi Arai; Kayoko Konuma; Toyoaki Sawano; Yoshiaki Kanemoto; Hirotomo Miyatake; Tomohiro Kurokawa; Yukiko Kouchi; Norio Kanzaki; Yasuhiro Kotera; Yoshitake Takebayashi; Michio Murakami; Tohru Ohtake; Hiroaki Shimmura; Akihiko Ozaki

作者单位Clinical Research Center, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan; Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, North Cartolina, USA; Breast and Thyroid Center, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan; Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan; Department of Breast Surgery, Utsunomiya Central Clinic, Utsunomiya, Japan; Department of Breast Cancer, St. Luke's International Hospital, Tokyo, Japan; Department of Nursing, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan; Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan; Yushoukai Medical Corporation Nobishiroclinic, Fujisawa, Japan; Department of Urology, Jyoban Hospital of Tokiwa Foundation, Iwaki, Japan; School of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom; Department of Health Risk Communication, Fukushima Medical University School of Medicine, Fukushima, Japan; Center for Infectious Disease Education and Research, The University of Osaka, Suita, Japan; EIPM Center, The University of Osaka, Suita, Japan

PDF源文件 DOI 网页
56 天

Beyond safety: rethinking concomitant radiotherapy and trastuzumab deruxtecan in metastatic breast cancer — from feasibility to precision practice

作者Yueting Tan; Benyuan Cheng; Kun He; Xiaobing Xie

作者单位Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China; The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, 410007, China

PDF源文件 DOI 网页
207 天

Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer

作者Dario Trapani; Sachin Kumar Deshmukh; Sharon Wu; Joanne Xiu; Priya Jayachandran; Shipra Gandhi; Nancy U. Lin; Giuseppe Curigliano; Philip M. Spanheimer; Daniel L. Abravanel; Milan Radovich; Maryam Lustberg; Stephanie L. Graff; George W. Sledge; Sara M. Tolaney; José P. Leone

作者单位Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Caris Life Sciences, Phoenix, AZ, USA; El Camino Hospital, Mountain View, CA, USA; Winship Cancer Institute, Emory University, Atlanta, GA, USA; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Yale School of Medicine, Yale University, New Haven, CT, USA; Lifespan Cancer Institute, Legorreta Cancer Center, Brown University, Providence, RI, USA

PDF源文件 DOI 网页
66 天

Local treatment for HER2-positive or triple negative second ipsilateral breast cancer event: A propensity score-matched analysis of the GEC-ESTRO database

作者J.M. Hannoun-Levi; J. Gal; C. Weltens; V. Smanyko; D. Kauer-Domer; D. Pasquier; C. Lemanski; S. Racadot; G. Houvenaeghel; B. Guix; A. Belliere-Calandry; K. Loessl; B. Polat; C. Gutierrez; R. Galalae; C. Polgar; R. Schiappa; V. Strnad

作者单位Department of Radiation Oncology, Antoine Lacassagne Cancer Centre, University of Côte d’Azur, Nice, France; University Côte d’Azur, Institut Hospitalo-Universitaire (IHU) RespirERA, 27 Rue du Professeur Delvalle, Nice, 06000, France; Department of Radiation Oncology, Radiation Oncology, University Hospital Gasthuisberg, Leuven, Belgium; Centre of Radiotherapy, National Institute of Oncology, Budapest, Hungary; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria; Department of Radiation Oncology, Oscar Lambret Cancer Centre, Lille University, Lille, France; Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France; Department of Radiation Oncology, Leon Berard Cancer Centre, Lyon, France; Department of Surgical Oncology, Paoli-Calmettes Cancer Institute, Marseille, France; Department of Radiation Oncology, Medical Institute for Radiotherapy & Oncology, Barcelona, Spain; Department of Radiation Oncology, Auvergne Jean Perrin Cancer Centre, Clermont-Ferrand, France; Department of Radiation Oncology, Radiation Oncology, Inselspital, Bern University Hospital, Switzerland; Department of Radiation Oncology, Wurzburg University, Wurzburg, Germany; Department of Radiation Oncology, Hospital del Mar, Brachytherapy Unite, Catalan Institute of Oncology, Barcelona, Spain; MedAustron Centre for Ion Therapy and Research, Wiener Neustadt, Austria; Radiotherapy Centre, National Institute of Oncology, Budapest, Hungary; Department of Radiotherapy, Semmelweis University, Budapest, Hungary; Department of Radiation Oncology, Erlangen University Hospital, Erlangen, Germany

PDF源文件 DOI 网页
307 天

The genomic landscape of HER2 negative metastatic breast cancer with loss of estrogen and progesterone receptors

作者Ilenia Migliaccio; Marta Paoli; Chiara Biagioni; Cristina Guarducci; Francesca Galardi; Giulia Anichini; Laura Biganzoli; Matteo Benelli; Luca Malorni

作者单位Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy; Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy; Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy

PDF源文件 DOI 网页
140 天

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial

作者Frédérique Penault-Llorca; Amelie Lusque; Thomas Filleron; Kevin Tran; Lili Du; Rick Baehner; Florence Dalenc; Magali Lacroix-Triki; Thomas Bachelot; Fabrice Andre; Pascal Boucher; Jérôme Lemonnier; W. Fraser Symmans

作者单位Department of Biopathology, Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, F-63000, France; Biostatistics & Health Data Science Unit, University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Exact Sciences, Madison, WI, USA; Department of Pathology, University of California, San Francisco, CA, USA; Department of Medical Oncology, Oncopole Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France; Department of Pathology, Institut Gustave Roussy, Villejuif, France; Department of Medical Oncology, Centre Leon Berard, Lyon, France; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Unicancer, Paris, France

PDF源文件 DOI 网页
103 天

PREDICT version 3.1 overestimates survival in older women with breast cancer: a population-based external validation

作者Julia N. Wolbink; Leti van Bodegom-Vos; Luuk C.A. Ciere; Saskia le Cessie; Hein Putter; Anna Z. de Boer; Willeke van der Plas-Krijgsman; Frederiek van den Bos; Gerrit-Jan Liefers; Johanneke E.A. Portielje

作者单位Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands; Department of Gerontology and Geriatrics, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands; Department of Clinical Epidemiology, Leiden University Medical Centre, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands; Department of Oncology, Medical Center Haaglanden, P.O. Box 432, The Hague, 2501 CK, the Netherlands; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands

PDF源文件 DOI 网页
187 天

Diagnostic accuracy of intraoperative macroscopic margin evaluation in breast-conserving surgery

作者C Florin Pop; Claudia Sanciu-Pop; Mathilde Lecomte; Etienne El-Helou; Michel Moreau; Guzel Dzhamalova; Brigitte Verheyden; Chirine Khaled; Denis Larsimont; Isabelle Veys; Gabriel Liberale

作者单位Department of Surgical Oncology, Institut Jules Bordet, The Brussels University Hospital (HUB), Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, CHU de Liege, Liege, Belgium; Data Centre and Statistics Department, Institut Jules Bordet, The Brussels University Hospital (HUB), Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, Institut Jules Bordet, The Brussels University Hospital (HUB), Université Libre de Bruxelles, Brussels, Belgium

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。